Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Lorenz

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|July 5, 2003
Inferring genetic networks and identifying compound mode of action via expression profilingTimothy S Gardner, Diego di Bernardo, David Lorenz, et al.
BMC Bioinformatics|September 4, 2003
ELISA: structure-function inferences based on statistically significant and evolutionarily inspired observationsBoris E Shakhnovich, John M Harvey, Steve Comeau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 23, 2017
Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected AdultsShibani S Mukerji, Vikas Misra, David Lorenz, et al.
JACC. Cardiovascular Interventions|March 15, 2023
Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO StudyKendra J Grubb, Hemal Gada, Suneet Mittal, et al.
JACC. Cardiovascular Interventions|June 30, 2025
30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum StudyHemal Gada, Ramzi F Khalil, Stanley J Chetcuti, et al.
JACC. Cardiovascular Interventions|June 1, 2026
First Large Comprehensive Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Final Global Results from the Optimize PRO Prospective StudyDanny Dvir, Hasan A Jilaihawi, Douglas Fraser, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|July 5, 2003
Inferring genetic networks and identifying compound mode of action via expression profilingTimothy S Gardner, Diego di Bernardo, David Lorenz, et al.
BMC Bioinformatics|September 4, 2003
ELISA: structure-function inferences based on statistically significant and evolutionarily inspired observationsBoris E Shakhnovich, John M Harvey, Steve Comeau, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 23, 2017
Temporal Patterns and Drug Resistance in CSF Viral Escape Among ART-Experienced HIV-1 Infected AdultsShibani S Mukerji, Vikas Misra, David Lorenz, et al.
JACC. Cardiovascular Interventions|March 15, 2023
Clinical Impact of Standardized TAVR Technique and Care Pathway: Insights From the Optimize PRO StudyKendra J Grubb, Hemal Gada, Suneet Mittal, et al.
JACC. Cardiovascular Interventions|June 30, 2025
30-Day and 1-Year Outcomes From the Optimize PRO TAVR Evolut FX Addendum StudyHemal Gada, Ramzi F Khalil, Stanley J Chetcuti, et al.
JACC. Cardiovascular Interventions|June 1, 2026
First Large Comprehensive Core-Laboratory Evaluation of Implantation Depth and Clinical Outcomes in TAVR: Final Global Results from the Optimize PRO Prospective StudyDanny Dvir, Hasan A Jilaihawi, Douglas Fraser, et al.
Pageof 1